Out of stock

This item is currently unavailable

Gone for 76 days. Could come back at any time — we're watching for you.

Out of stock 76 days

World Outlook for Bladder Cancer Therapeutics 2025-2030

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 76 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

Stay informed with The 2025-2030 World Outlook for Bladder Cancer Therapeutics. This specialized publication from ICON Group International, Inc. provides essential perspectives on the evolving landscape of bladder cancer treatments and therapeutic developments. Designed for professionals in the medical and research fields, this book offers a comprehensive outlook on the industry trajectory through 2030. It serves as a vital resource for understanding upcoming trends and advancements in bladder cancer care on a global scale.

Key Features

Provides a detailed world outlook for bladder cancer therapeutics covering the years 2025 through 2030.

Published by ICON Group International, Inc. to ensure industry-specific expertise.

Categorized under professional books for specialized subject matter research.

Offers a long-term view of the therapeutic landscape for bladder cancer treatments.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
25 March 2024

Similar Products You Might Like

World Outlook: Transitional Cell Bladder Cancer Therapeutics
98% match

World Outlook: Transitional Cell Bladder Cancer Therapeutics

Price unavailable
Bladder Cancer Therapeutics Outlook Japan 2016-2021
98% match

Bladder Cancer Therapeutics Outlook Japan 2016-2021

£595.00 28 Aug 2026
Overactive Bladder Treatments in India 2023-2028 Outlook
97% match

Overactive Bladder Treatments in India 2023-2028 Outlook

£515.00 25 Aug 2026
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care
97% match

Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care

Elsevier

£119.36 24 Sep 2026
US Overactive Bladder Treatment Outlook 2023-2028 Study
97% match

US Overactive Bladder Treatment Outlook 2023-2028 Study

£520.00 28 Aug 2026
The 2026-2031 World Outlook for Overactive Bladder Treatments
97% match

The 2026-2031 World Outlook for Overactive Bladder Treatments

£885.00 28 Oct 2026
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
97% match

The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics

Price unavailable
World Outlook for Cancer Therapies 2025-2030 Report
97% match

World Outlook for Cancer Therapies 2025-2030 Report

Price unavailable
The 2026-2031 World Outlook for Overactive Bladder Therapeutics
97% match

The 2026-2031 World Outlook for Overactive Bladder Therapeutics

£885.00 19 Sep 2026
The 2023-2028 Outlook for Overactive Bladder Treatments in China
97% match

The 2023-2028 Outlook for Overactive Bladder Treatments in China

£495.00 07 Nov 2026
World Outlook for Blood Cancer Therapeutics 2025-2030
96% match

World Outlook for Blood Cancer Therapeutics 2025-2030

Price unavailable
The 2023-2028 Outlook for Overactive Bladder Treatments in Japan
96% match

The 2023-2028 Outlook for Overactive Bladder Treatments in Japan

£495.00 03 Nov 2026
World Outlook for Cancer Specialty Hospitals 2025-2030
96% match

World Outlook for Cancer Specialty Hospitals 2025-2030

Price unavailable
Overactive Bladder Treatments Outlook 2023-2028 Report
96% match

Overactive Bladder Treatments Outlook 2023-2028 Report

£490.00 05 Nov 2026
Uterine Cancer Therapeutics and Diagnostics in India Outlook
96% match

Uterine Cancer Therapeutics and Diagnostics in India Outlook

£515.00 05 Nov 2026
Current Management of Superficial Bladder Cancer, An Issue of Urologic Clinics of North America: Volume 53-3 (The Clinics: Surgery, Volume 53-3)
96% match

Current Management of Superficial Bladder Cancer, An Issue of Urologic Clinics of North America: Volume 53-3 (The Clinics: Surgery, Volume 53-3)

Elsevier

£85.99 26 Sep 2026
Update on Bladder Cancer
96% match

Update on Bladder Cancer

IntechOpen

£100.00 22 Sep 2026
The 2025-2030 World Outlook for Cancer Screenings
96% match

The 2025-2030 World Outlook for Cancer Screenings

Price unavailable
Metabolomics of Bladder Cancer: An Emerging Application
96% match

Metabolomics of Bladder Cancer: An Emerging Application

Elsevier

£130.56 03 Oct 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 17 Sep 2026
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
96% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£520.00 06 Nov 2026
The 2013-2018 World Outlook for Overactive Bladder (OAB) Therapeutics
96% match

The 2013-2018 World Outlook for Overactive Bladder (OAB) Therapeutics

£795.00 28 Oct 2026
The 2025-2030 World Outlook for Blockbuster Oncology Brands
96% match

The 2025-2030 World Outlook for Blockbuster Oncology Brands

Price unavailable
Textbook of Bladder Cancer
96% match

Textbook of Bladder Cancer

CRC Press

£119.99 25 Sep 2026